• Home
  • Latest
  • Fortune 500
  • Finance
  • Tech
  • Leadership
  • Lifestyle
  • Rankings
  • Multimedia
Right Arrow Button IconLeft Arrow Button IconHome
Right Arrow Button IconBill Ackman

Bill Ackman

Page 15 of 18
Pershing Square's Bill Ackman and Valeant Pharmaceuticals International's Michael Pearson Interview
FinanceBill Ackman Bought More Valeant
By Lucinda ShenFebruary 17, 2016
Hedge fund manager Bill Ackman
FinanceWhy You Are a Better Investor Than Bill Ackman
By Stephen GandelFebruary 11, 2016
Squawk Box - Season 20
FinanceHere’s What Wall Street Thinks of Bill Ackman’s New Herbalife Attack
By Jen WiecznerFebruary 9, 2016
Key Speakers At The Bloomberg Markets Most Influential Summit
FinanceActivist Hedge Funds Have Their Worst Month in Years
By Stephen GandelFebruary 5, 2016
J. Michael Pearson, chief executive officer, Valeant Pharmaceuticals International Inc., speaks during the Bloomberg Economic Series: Canada 2015 in Toronto, Ontario Thursday May 21/2015. (Photo by Kevin Van Paassen/Bloomberg)
FinanceBiotech Stocks Crashed and Nobody Knows Why
By Jen WiecznerJanuary 28, 2016
Key Speakers At The Bloomberg Markets Most Influential Summit
FinanceHedge Fund Billionaire Bill Ackman Admits He Made Mistakes
By ReutersJanuary 27, 2016
Key Speakers At The Bloomberg Markets Most Influential Summit
FinanceBill Ackman Just Had a Really Lousy Year
By ReutersJanuary 5, 2016
Key Speakers At The Bloomberg Markets Most Influential Summit
FinanceBill Ackman says his fund is having its worst year ever
By ReutersDecember 16, 2015
Key Speakers At The Bloomberg Markets Most Influential Summit
FinanceBill Ackman Just Boosted His Valeant Stake
By ReutersNovember 24, 2015
Bill Ackman
HealthValeant, Ackman Must Face U.S. Insider Trading Lawsuit
By ReutersNovember 11, 2015
Key Speakers At The 20th Annual Sohn Investment Conference
FinanceBill Ackman thought Valeant was the next Berkshire Hathaway
By Jen WiecznerOctober 30, 2015
Hedge fund manager Bill Ackman
FinanceBill Ackman on Valeant: ‘Life will go on’
By Stephen GandelOctober 30, 2015
J. Michael Pearson, Chairman of the board and Chief Executive Officer of Valeant Pharmaceuticals International Inc., waits for the start of their annual general meeting in Laval, Quebec
HealthValeant cuts ties to controversial pharmacy chain Philidor
By Geoffrey SmithOctober 30, 2015
Hedge fund manager Bill Ackman
FinanceAnother one of Bill Ackman’s top stocks is down 50%
By Jen WiecznerOctober 29, 2015
Hedge fund manager Bill Ackman
FinanceWhat the drop in Valeant’s stock says about hedge funds’ herd mentality
By Stephen GandelOctober 25, 2015
1...
  • 13
  • 14
  • 15
  • 16
  • 17
18
Most Popular
Law
DOGE cancelled a $349,000 grant to replace a museum’s HVAC after ChatGPT flagged it as DEI, court documents showAn image of a popular article
By Fortune EditorsMarch 19, 2026
Economy
Social Security has 6 years left. The fix that sounds cruelest may be the smartestAn image of a popular article
By Fortune EditorsMarch 19, 2026
Economy
Jerome Powell says you're right to blame data centers for making your bills more expensive: 'probably pushing inflation up'An image of a popular article
By Fortune EditorsMarch 19, 2026
Fortune Secondary Logo
Rankings
  • 100 Best Companies
  • Fortune 500
  • Global 500
  • Fortune 500 Europe
  • Most Powerful Women
  • Future 50
  • World’s Most Admired Companies
  • See All Rankings
Sections
  • Finance
  • Fortune Crypto
  • Features
  • Leadership
  • Health
  • Commentary
  • Success
  • Retail
  • Mpw
  • Tech
  • Lifestyle
  • CEO Initiative
  • Asia
  • Politics
  • Conferences
  • Europe
  • Newsletters
  • Personal Finance
  • Environment
  • Magazine
  • Education
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Terms Of Use
  • Single Issues For Purchase
  • International Print
Commercial Services
  • Advertising
  • Fortune Brand Studio
  • Fortune Analytics
  • Fortune Conferences
  • Business Development
  • Group Subscriptions
About Us
  • About Us
  • Editorial Calendar
  • Press Center
  • Work At Fortune
  • Diversity And Inclusion
  • Terms And Conditions
  • Site Map
  • About Us
  • Editorial Calendar
  • Press Center
  • Work At Fortune
  • Diversity And Inclusion
  • Terms And Conditions
  • Site Map
  • Facebook icon
  • Twitter icon
  • LinkedIn icon
  • Instagram icon
  • Pinterest icon

© 2026 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
FORTUNE is a trademark of Fortune Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.